相关实验视频

Updated: May 26, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

疫苗开发T细胞 (MHC-I) 皮质标识对抗印度HCV基因型:基于免疫信息学的方法

Sridevi Iyyanar¹, Sai Nandhini Ravi²

¹Department of Biotechnology, Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology, Chennai, Tamil Nadu, India.

Molecular biotechnology

|February 24, 2025

概括

这项研究通过分析病毒蛋白质结构和使用计算方法,确定了对型肝炎C病毒 (HCV) 潜在的类疫苗候选人. 目标是为更好的免疫疗法提供特定人群疫苗.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
计算生物学计算生物学

背景情况:

型肝炎病毒 (HCV) 影响全球数百万人,导致严重的肝脏疾病.
E1和E2糖蛋白是HCV进入的关键,也是抗体的目标.
现在可以获得E1E2复合体的高分辨率结构数据.

研究的目的:

使用结构和计算方法设计一种针对HCV的合成类疫苗.
确定针对HCV E1和E2糖蛋白保护区域的免疫原性表位.
为印度人群制定一个特定人群的疫苗策略 (HLA-A*24:02).

主要方法:

使用了HCV E1E2异构体的冷电子断层扫描结构.
用免疫信息学和蛋白质结构建模来进行表位查.
进行了分子对接和GROMACS分子动力学模拟,用于结合亲和力和稳定性分析.

主要成果:

确定了KWEYVVLLF和QWQVLPCSF作为HLA-A*24:02.02的有希望的表征物.
对这些表位基因与HLA-A*24:02.02实现了高亲和度结合得分.
分子动力学证实了潜在免疫性稳定的结合相互作用.

结论:

已确定的表位是基于T细胞的HCV疫苗的强有力的候选者.
反向疫苗学与计算工具相结合,使得特定人群的疫苗开发成为可能.
这种方法推进了对C型肝炎的精密免疫疗法.

关键词:

这里是格罗马克斯.在 HLA-A*24:02 中.肝炎C病毒感染者免疫信息学是指免疫信息学.分子对接是分子对接.反向接种疫苗的方法的T细胞表位.疫苗的设计是如何设计的

更多相关视频

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

相关概念视频

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...